Case study

Trial Tokenization to Understand the Long Term Effectiveness of a New COVID-19 Vaccine

A biopharma company was conducting a Phase III study to assess the safety and effectiveness of a new COVID-19 vaccine. They needed to identify and connect to real-world data sources that would enable observation of infection rates and adverse events beyond the period of the trial.

Download our case study to learn how this client is using Datavant to tokenize their trial data and connect it to real-world data to complete their evaluation of the vaccine’s safety and effectiveness.

Achieve your boldest ambitions

Explore how Datavant can be your health data logistics partner.

Contact us